Eyedentity raised 15 million SEK from Norrsken Launcher to develop its AI tool for detecting uveal melanoma.

Provenance

Sources

1. EU-Startups · 21 Aug 2026

   Stockholm-based Eyedentity secures €1.3 million to detect deadly eye cancer earlier with AI

   MedTech startup Eyedentity has closed its first oversubscribed investment round at €1.3 million (SEK 15 million) to support regulatory approval, further product development and the expansion of…

2. Breakit · 20 Aug 2026

   Norrsken vill stötta god AI – ska hitta dödlig cancer med Eyedentity

   Deras AI-verktyg ska upptäcka en lömsk och dödlig cancer och sluta skicka friska patienter till en redan hårt pressad vård. Nu får Eyedentity in 15 miljoner kronor och en ny ägare i Norrsken Launcher.